Skip to content
Signal Bureau What’s happening · what the record shows

ASCO

Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.

American Society of Clinical Oncology — The leading U.S. professional body for cancer physicians; its annual meeting is where major trial results debut.

Coverage of ASCO is holding steady : 3 signals on the latest tracked day, level with its three-week baseline of 3, across 3 domains (unchanged from a week ago).

ASCO is steady by its own history. Its normal rhythm is about 3 signals a day across 3 domains (2 tracked days). A real move would be a day at 4+ signals — 25% above that baseline, the bar our trend read calls accelerating — or a spread into domains beyond its usual 3. That is the move that would push it up the Wire.

What’s changed

What the reporting says

It shows up alongside Overall Survival (32), Breast Cancer (21), Her2 (19), Cancer Center (14), Her2 Negative (11), Colorectal Cancer (23), Immunotherapy (22), FDA (19).

Two steps out: Clinical Trials (through Overall Survival, 31 shared stories on the weaker link); Lung Cancer (through Overall Survival, 28 shared stories on the weaker link); ctDNA (through Overall Survival, 27 shared stories on the weaker link); Braf (through Colorectal Cancer, 23 shared stories on the weaker link).

Tracked since Jun 3, with coverage on 27 separate days — concentrated in Society News.

Ask the engine about ASCO ＋ Track ASCO for a daily read
Counts computed from our committed signal record (Sep 9 – Sep 11, 2 tracked days). Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Sep 12, 12:50 PM PT